Position in PCVX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,278,278
-$142,453 QoQ
Shares Held
21,990
-10.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#153
of 329 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. PCVX ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in PCVX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,278,278 | 21,990 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,420,731 | 24,449 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,233,091 | 26,725 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $871,720 | 24,201 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $995,098 | 30,609 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,234,449 | 32,692 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,346,027 | 40,875 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,330,513 | 29,146 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,580,726 | 20,934 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,821,622 | 26,667 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,356,919 | 21,607 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $934,055 | 18,322 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $899,918 | 18,020 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $524,345 | 13,990 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $755,692 | 15,760 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $262,248 | 10,927 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $227,674 | 10,463 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $333,922 | 13,827 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $386,706 | 16,255 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $414,215 | 16,327 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $439,935 | 19,544 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $292,181 | 14,794 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $316,103 | 11,897 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||